Press Releases 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Receives 180 Days of Marketing Exclusivity for Recently Approved Vasopressin 12/29/21 Eagle Pharmaceuticals Reports that Par Has Unilaterally Withdrawn Attempt to Halt Launch of Vasopressin 12/20/21 Eagle Pharmaceuticals Receives FDA Approval for Vasopressin 12/15/21 Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 11/22/21 Eagle Pharmaceuticals Reports Third Quarter 2021 Results 11/9/21 Eagle Pharmaceuticals to Host Third Quarter 2021 Financial Results on November 9, 2021 10/28/21 Reminder: Eagle Pharmaceuticals to Host CAL02 Investor Event on September 9, 2021 9/7/21 Eagle Pharmaceuticals to Present at September Healthcare Conferences 9/1/21 Eagle Pharmaceuticals Wins Vasopressin Patent Trial 8/31/21 Eagle Pharmaceuticals Granted Additional Patent for Bendamustine Franchise 8/31/21 Pagination Current page 1 Page 2 Page 3 Next page Last page
